Lactoferricin B-derived peptides showed confirmed antihypertensive activity through ACE inhibition and other mechanisms, adding blood pressure management to the milk peptide's antimicrobial and anticancer profiles.
Key findingLactoferricin B-derived peptides showed confirmed antihypertensive activity through ACE inhibition and other mechanisms, adding blood pressure managem
What the researchers found
Lactoferricin B-derived peptides showed confirmed antihypertensive activity through ACE inhibition and other mechanisms, adding blood pressure management to the milk peptide's antimicrobial and anticancer profiles.
Why it matters
Relevant for peptide research.
How the study worked
research study.
What this study cannot tell us
See abstract.
How to read the evidence
emerging evidence.
When this study was published
Published in 2010.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
Common questions
What was studied?
What was found?
Read the original research
Antihypertensive properties of lactoferricin B-derived peptides.
Journal of agricultural and food chemistry, 58(11), 6721-7
Citation
Ruiz-Giménez, Pedro; Ibáñez, Aida; Salom, Juan B; Marcos, Jose F; López-Díez, Jose Javier; Vallés, Salvador; Torregrosa, Germán; Alborch, Enrique; Manzanares, Paloma. (2010). Antihypertensive properties of lactoferricin B-derived peptides.. Journal of agricultural and food chemistry, 58(11), 6721-7. https://doi.org/10.1021/jf100899u